Condition
Endocannabinoids
Total Trials
3
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 1 (1)
Trial Status
Completed3
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT03407937Not ApplicableCompleted
The Effect of Hypnosis on Blood Concentrations of Endocannabinoids
NCT02727023Not ApplicableCompleted
Effect of OMM on Anandamide Levels in Saliva
NCT00628706Phase 1Completed
Investigating the Acute Effects of THC on Functional Brain Systems
Showing all 3 trials